The American Academy of Optometry’s annual meeting, Academy 2024, held in Indianapolis, Indiana, showcased groundbreaking research and cutting-edge advancements in the field of optometry and vision sciences. Among the distinguished contributors, WashU Medicine faculty members and researchers stood out, bringing innovative ideas to the forefront.
One such contribution came from Dr. Eric Polk, OD, FAAO, who presented a poster titled “Topical Losartan for Corneal Scarring Secondary to Corneal Inlay.” This important work highlights the potential of topical losartan—a medication traditionally used for managing hypertension—as a novel treatment option for corneal scarring. Dr. Polk’s research delves into how this approach may improve outcomes for patients with complications arising from corneal inlays.
This collaborative effort was made possible through the support and insights of Steven Wexler, MD the study’s second author. Together, their work underscores the commitment of WashU Medicine’s Department of Ophthalmology and Vision Sciences to advancing eye care through innovative treatments and clinical solutions.
Academy 2024 serves as an essential platform for professionals to exchange knowledge and drive progress in the field of optometry. The contributions from WashU Medicine further solidify its role as a leader in ophthalmic education and research, ensuring patients worldwide benefit from the latest advancements.